Report top-line results for three Phase 3 trials of PF-06482077
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 28 Jan 2020
- Due
- 30 Jun 2020
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“for three Phase 3 trials of PF-06482077, our 20-valent pneumococcal conjugate vaccine candidate in adults aged 18 and older”
What we found
Evidence strength A What the grades mean
Pfizer reported results for only one Phase 3 study of PF-06482077 by the deadline, not three as committed.
-
A Pfizer Inc. 8-K filed 2020-07-28
“In May 2020, Pfizer announced positive top-line results from a second Phase 3 study (NCT03828617)” ✓ confirmed on the page
-
A Pfizer Inc. 8-K filed 2020-10-27
“In October 2020, Pfizer presented the full analysis from a Phase 3 study” ✓ confirmed on the page
Market reaction: the shares moved -4.2% against the S&P 500 over the three sessions around the disclosure (26 Oct 2020 to 29 Oct 2020). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout late
- Indicative materiality
- High rules
- Action
- Report
- Deliverable
- PF-06482077 Phase 3 trial results
- Target
- 3 trials
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Partly met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and reads it as “no_evidence”.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Pfizer Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-PFE-001731 · Corrections policy